Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) • By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors ,
Benzodiazepines. Antipsychotics, Novel Agents • By Sales Channel - Hospital & Clinics, Retail Pharmacies, Others • By Region- APAC , North America, Europe and RoW • By Country - United States, Canada, United Kingdom, Germany, , China, India, Japan, Brazil, South Arabia
February 2018
Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC , N. America, Europe , RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia) Scope of the Study
Global Coverage
By Drugs Class
Regional Coverage
By Sales Channels
Country Coverage Global Coverage
Regional Coverage
Region (North America, Europe, APAC, Rest of World ) Country (U.S., Canada, Germany, United Kingdom, India, China, Japan, Brazil, South Arabia)
Country Coverage
Company Coverage
North America Europe Asia Pacific Anti Depressants Drugs Market –
Rest of World
By Value (In USD Billion) -(20132023) By Drugs Class ( Tricyclic,
Serotonin-Norepinephrine Inhibitors, Antipsychotics, Selective Srotonin Reuptake Inhibitors, Benzodiazepines, Monoamine Oxidase Inhibitors, Novel Agents, Others) By Sales Channels (Hospitals &
U.S. Canada Germany United Kingdom India China Japan Brazil South Arabia
Segmentation By Sale Channels
Allergan Novartis Takeda
Forest Laboratories
(2013-2023)
Segmentation By Drugs Class
ELI LILLY
GlaxoSmithkiline
Antidepressant Drugs Market – By Value
PFIZER INC.
Anti Depressant Drugs Market – By Value (In USD Billion) (2013-2023) Breakdown-By - Drugs Class (2013-2023)
Product Benchmarking Business Overview Pipeline Analysis
Clinics, Retail Pharmacies, Others)
2
Table of Content S.No
Particulars
Page No.
1.
Research Methodology
18
2.
Executive Summary
19
3.
Strategic Recommendation
20
3.1
Focus on Asia Pacific Region
21
3.2
Focus on new antidepressant drugs development
22
4.
Antidepressant Drugs Market Outlook
23
5.
Global Antidepressant Drugs Market: Growth and Forecast
28
6.
5.1
By Value (2013-2017)
29
5.2
By Value (2018-2023)
34
Global Antidepressant Drugs Market: By Drugs Class 6.1
6.2
Global Antidepressant Drugs Market-By Drugs Class: Breakdown(%)
35 35
6.1.1
Global Antidepressant Drugs Market Size and Share, By Drugs, 2017
36
6.1.2
Global Antidepressant Drugs Market Size and Share, By Drugs, 2023
37
Global Selective Serotonin Reuptake Inhibitors Market Overview 6.2.1
By Value (2013-2023)
38 38
3
Table of Content S. No
Particulars
6.3
Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview 6.3.1
6.4
Global Monoamine Oxidase Inhibitors Market Overview 6.4.1
6.5
By Value (2013-2023)
Global Other Antidepressant Drugs Market Overview
6.9.1 7.
By Value (2013-2023)
Global Novel Agents Antidepressant Drugs Market Overview 6.8.1
6.9
By Value (2013-2023)
Global Antipsychotics Antidepressant Drugs Market Overview 6.7.1
6.8
By Value (2013-2023)
Global Benzodiazepines Antidepressant Drugs Market Overview 6.6.1
6.7
By Value (2013-2023)
Global Tricyclic Antidepressant Drugs Market Overview
6.5.1 6.6
By Value (2013-2023)
By Value (2013-2023)
Global Antidepressant Drugs Market: By Sales Channels 7.1
Global Antidepressant Drugs Market-By Sales Channels : Breakdown(%)
Page No.
42 42 44 44 46
46 48 48 50 50 52 52 53
53 54 54
7.1.1
Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017
55
7.1.2
Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023
56
4
Table of Content S. No
Particulars 7.2
Global Antidepressant Drugs Market By Hospital & Clinics Overview 7.2.1
7.3
Global Antidepressant Drugs Market By Retail Pharmacies Overview 7.3.1
7.4
By Value (2013-2023)
Global Antidepressant Drugs Market: Pipeline Analysis 8.1
9.
By Value (2013-2023)
Global Antidepressant Drugs Market By Others Overview 7.4.1
8.
By Value (2013-2023)
By Developer, Phase, Indication and Status
Global Antidepressant Drugs Market: Regional Analysis
9.1
9.2
9.3
Global Antidepressant Drugs Market, By Region: Breakdown (%)
Page No. 57 57 58 58 59 59 60 61 65
65
9.1.1
Global Antidepressant Drugs Market Size, By Region, 2017 (%)
66
9.1.2
Global Antidepressant Drugs Market Size, By Region, 2023 (%)
67
North America Antidepressant Drugs Market: An Analysis
68
9.2.1
By Value (2013-2017)
69
9.2.2
By Value (2018-2023)
70
North America Antidepressant Drugs Market: Segment Analysis
71
9.3.1
72
North America Antidepressant Drugs Market: By Drug Class 9.3.1.1
9.3.2
North America Antidepressant Drugs Market Size, By Value, 2013-2023
North America Antidepressant Drugs Market: By Sales Channels 9.3.2.1
North America Antidepressant Drugs Market Size, By Value, 2013-2023F
72 74 75
5
Table of Content S. No
Particulars 9.4
North America Antidepressant Drugs Market: Country Analysis (U.S. and Canada) 9.4.1
U.S. Antidepressant Drugs Market, By Value (2013-2023) 9.4.1.1
9.4.2
9.5
9.6
76 79 84
Canada Antidepressant Drugs Market, By Value (2013-2023)
87
9.4.2.2
89
Canada Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Europe Antidepressant Drugs Market: An Analysis
91
9.5.1
By Value (2013-2017)
92
9.5.2
By Value (2018-2023)
93
Europe Antidepressant Drugs Market: Segment Analysis 9.6.1
Europe Antidepressant Drugs Market: By Drugs Class 9.6.1.1
9.6.2
9.7
U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Page No.
Europe Antidepressant Drugs Market Size, By Value, 2013-2023
9.7.2
9.7.3
94 95
Europe Antidepressant Drugs Market: By Sales Channels
97
9.6.2.1
98
Europe Antidepressant Drugs Market Size, By Value, 2013-2023F
Europe Antidepressant Drugs Market: Country Analysis (U.K., Germany & Rest of Europe)
9.7.1
94
99
United Kingdom Antidepressant Drugs Market, By Value (2013-2023)
102
9.7.1.1
106
United Kingdom Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Germany Antidepressant Drugs Market, By Value (2013-2023)
109
9.7.2.1
112
Germany Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Rest of Europe Antidepressant Drugs Market, By Value (2013-2023)
114
6
Table of Content S. No
Particulars
9.8
9.9
Asia Pacific Antidepressant Drugs Market: An Analysis
115
9.8.1
By Value (2013-2017)
116
9.8.2
By Value (2018-2023)
117
Asia Pacific Antidepressant Drugs Market: Segment Analysis 9.9.1
9.9.2
118
Asia Pacific Antidepressant Drugs Market: By Drugs Class
118
9.9.1.1
119
Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023
Asia Pacific Antidepressant Drugs Market: By Sales Channels 9.9.2.1
9.10
Page No.
Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023F
121 122
Asia Pacific Antidepressant Drugs Market: Country Analysis (Germany, U.K., & Rest of Europe)
123
9.10.1
India Antidepressant Drugs Market, By Value (2013-2023)
126
9.10.1.1
130
9.10.2
China Antidepressant Drugs Market, By Value (2013-2023) 9.10.2.1
9.10.3
China Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Japan Antidepressant Drugs Market, By Value (2013-2023) 9.10.3.1
9.10.4
India Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Japan Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023)
133 136 140 143 145
7
Table of Content S. No
Particulars
9.11
9.12
Rest of World Antidepressant Drugs Market: An Analysis
146
9.11.1
By Value (2013-2017)
147
9.11.2
By Value (2018-2023)
148
Rest of World Antidepressant Drugs Market: Segment Analysis
149
9.12.1
Rest of World Antidepressant Drugs Market: By Drugs Class
149
9.12.1.1
150
9.12.2
9.13
Page No.
Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023
Rest of World Antidepressant Drugs Market: By Sales Channels
152
9.12.2.1
153
Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023F
Rest of World Antidepressant Drugs Market: Country Analysis (Brazil, Saudi Arabia & Others) 9.13.1
9.13.2
Brazil Antidepressant Drugs Market, By Value (2013-2023)
157
9.13.1.1
158
Brazil Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023) 9.13.2.1
9.13.3
154
Saudi Arabia Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Others Antidepressant Drugs Market, By Value (2013-2023)
161 162 164
8
Table of Content S. No
10.
Particulars
Market Dynamics
Page No.
165
10.1
Drivers
166
10.2
Challenges
169
11.
Market Trends
171
12.
Policy and Regulatory Landscape
173
13.
Porter’s Five Forces Analysis – Antidepressant Drugs Market
181
14.
SWOT Analysis –Antidepressant Drugs Market
183
15.
Company Profiling
185
15.1
Allergan
186
15.2
Eli Lilly
187
15.3
Pfizer
188
15.4
Takeda
190
15.5
GlaxoSmithKline
192
15.6
Novartis
193
15.7 16.
About Us
Forest Laboratories
195 196
9
List of Figures Figure No.
Figure Title
Page No.
Figure 1:
Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
29
Figure 2:
Global YLDs of Depressive Disorders (2013-2016, %)
30
Figure 3:
Global DALYs of Anxiety Disorders (2013-2016 %)
30
Figure 4:
DALYs due to Mental and Substance Abuse (2016)
30
Figure 5:
World Female Population, 2012-2016 (Million)
31
Figure 6:
World Population 65 Years & Above (% of Total), 2012-2016
31
Figure 7:
Global Unemployment (2016, 2017E, 2018F, (Millions)
32
Figure 8:
Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
33
Figure 9:
Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
33
Figure 10:
Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion)
34
Figure 11:
Global Antidepressant Drugs Market Size, By Drugs, 2017 (%)
36
Figure 12:
Global Antidepressant Drugs Market Size, By Drugs Class, 2023F (%)
37
Figure 13:
Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
38
Figure 14:
Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
38
Figure 15:
SSRIs Antidepressants Usage in Different Disorders (%)
40
Figure 16:
Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
42
Figure 17:
Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E2023F (USD Billion)
42
Figure 18:
Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
44
Figure 19:
Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
44
10
List of Figures Figure No.
Figure Title
Page No.
Figure 20:
Global Tricyclic Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
46
Figure 21:
Global Tricyclic Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
46
Figure 22:
Global Benzodiazepines Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
48
Figure 23:
Global Benzodiazepines Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
48
Figure 24:
Global Antipsychotics Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
50
Figure 25:
Global Antipsychotics Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
50
Figure 26:
Global Novel Agents Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
52
Figure 27:
Global Novel Agents Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
52
Figure 28:
Global Others Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
53
Figure 29:
Global Others Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
53
Figure 30:
Global Antidepressant Drugs Market Size, By Sales Channels, 2017 (%)
55
Figure 31:
Global Antidepressant Drugs Market Size, By Sales Channels, 2023 (%)
56
Figure 32:
Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2013-2017 (USD Billion)
57
Figure 33:
Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2018E-2023F (USD Billion)
57
Figure 34:
Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2013-2017 (USD Billion)
58
Figure 35:
Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2018E-2023F (USD Billion)
58
Figure 36:
Global Antidepressant Drugs Market, By Others, By Value, 2013-2017 (USD Billion)
59
Figure 37:
Global Antidepressant Drugs Market, By Others, By Value, 2018E-2023F (USD Billion)
59
Figure 38:
Global Antidepressant Drugs Market Size and Share, By Region, 2017
66
Figure 39:
Global Antidepressant Drugs Market Size and Share, By Region, 2023F
67
11
List of Figures Figure No.
Figure Title
Page No.
Figure 40:
North America Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
69
Figure 41:
North America Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
70
Figure 42:
North America Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
72
Figure 43:
North America Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
75
Figure 44:
North America Antidepressant Drugs Market, Country Share, 2017 (% of Total)
77
Figure 45:
North America Antidepressant Drugs Market, Country Share, 2023 (% of Total)
77
Figure 46:
United States Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
79
Figure 47:
United States Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
79
Figure 48:
United States YLDs by Anxiety Disorders (2013-2016 %)
80
Figure 49:
United States YLDs by Depressive Disorders (2013-2016 %)
80
Figure 50:
United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016)
80
Figure 51:
United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016)
81
Figure 52:
Treatment Received Among Adults with Major Depressive Episode (2016)
81
Figure 53:
Per Capita Healthcare Expenditure in United States (2012-2016, USD)
82
Figure 54:
U.S Health Spending by Type of Service or Product, 2016 (%)
82
Figure 55:
U.S Health Spending by Type of Service or Product, 2016 (%)
84
Figure 56:
Canada Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
87
Figure 57:
Canada Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
87
Figure 58:
Canada Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
89
Figure 59:
Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
92
Figure 60:
Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
93
12
List of Figures Figure No.
Figure Title
Page No.
Figure 61:
Europe Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
95
Figure 62:
Europe Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
98
Figure 63:
Europe Antidepressant Drugs Market, Country Share, 2017 (% of Total)
100
Figure 64:
Europe Antidepressant Drugs Market, Country Share, 2023 (% of Total)
100
Figure 65:
United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
102
Figure 66:
United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
102
Figure 67:
United Kingdom YLDs by Depressive Disorders (2013-2016 %)
103
Figure 68:
Antidepressant Dispensed in England (2005, 2015, 2016, Million Units)
103
Figure 69:
United Kingdom YLDs by Anxiety Disorders (2013-2016 %)
103
Figure 70:
Per Capita Healthcare Expenditure in United Kingdom (2012-2016, USD)
104
Figure 71:
U.K. Population 65 Years & Above (% of Total), 2012-2016
104
Figure 72:
United Kingdom Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
106
Figure 73:
Germany Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
109
Figure 74:
Germany Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
109
Figure 75:
Private Healthcare Spending in Germany, US Dollar/capita (2012-2016)
110
Figure 76:
Germany Per Capita Healthcare Expenditure (2012-2016, USD)
110
Figure 77:
Germany YLDs & DALYs by Depressive Disorders (2013-2016 %)
110
Figure 78:
Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
112
Figure 79:
Rest of Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
114
Figure 80:
Rest of Europe Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
114
13
List of Figures Figure No.
Figure Title
Page No.
Figure 81:
Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
116
Figure 82:
Asia Pacific Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
117
Figure 83:
Asia Pacific Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion
119
Figure 84:
Asia Pacific Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
122
Figure 85:
Asia Pacific Antidepressant Drugs Market, Country Share, 2017 (% of Total)
124
Figure 86:
Asia Pacific Antidepressant Drugs Market, Country Share, 2023 (% of Total)
124
Figure 87:
India Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
126
Figure 88:
India Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
126
Figure 89:
Prevalence of Depressive Disorders in India By Age and Sex- (2015-2016)
127
Figure 90:
India Healthcare Expenditure (2012-2016, USD Billion)
128
Figure 91:
India Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
130
Figure 92:
China Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
134
Figure 93:
China Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
134
Figure 94:
China YLDs by Anxiety Disorders (2013-2016 %)
135
Figure 95:
China YLDs & DALYs by Depressive Disorders (2013-2016 %)
135
Figure 96:
China Healthcare Expenditure (2012-2016, USD Billion)
136
Figure 97:
China Population 65 Years & Above (% of Total), 2012-2016
136
Figure 98:
China Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
137
Figure 99:
Japan Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
140
Japan Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
140
Figure 100:
14
List of Figures Figure No.
Figure Title
Page No.
Figure 101:
Japan Per Capita Health Expenditure (2012-2016, USD)
141
Figure 102:
Japan YLDs by Depressive Disorders (2013-2016 %)
141
Figure 103:
Japan YLDs by Depressive Disorders (2013-2016 %)
141
Figure 104:
Japan Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
143
Figure 105:
Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
145
Figure 106:
Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
145
Figure 107:
Rest of World Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
147
Figure 108:
Rest of World Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
148
Figure 109:
Rest of World Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
150
Figure 110:
Rest of World Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
153
Figure 111:
Rest of World Antidepressant Drugs Market, Country Share, 2017 (% of Total)
155
Figure 112:
Rest of World Antidepressant Drugs Market, Country Share, 2023 (% of Total)
155
Figure 113:
Brazil Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
157
Figure 114:
Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
157
Figure 115:
Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
158
Figure 116:
Saudi Arabia Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
161
15
List of Figures Figure No.
Figure Title
Page No.
Figure 117:
Saudi Arabia Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
162
Figure 118:
Saudi Arabia Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
162
Figure 119:
Others Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
164
Figure 120:
Others Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
164
Figure 121:
Pfizer Segmental Breakup, 2016 (%)
189
Figure 122:
Pfizer Sales, By Region, 2016 (%)
189
Figure 123:
Takeda Segmental Break Up
191
Figure 124:
Takeda Geographical Break Up
191
Figure 125:
Novartis Sales, By Segment 2015 (%)
194
Figure 126:
Novartis Sales, By Region, 2015 (%)
194
Figure 127:
Novartis Pharmaceuticals Sales, By Franchise, 2015 (%)
194
16
List of Tables Table No.
Table Title
Page No.
Table A:
List of Major Antidepressant Drugs Include in SSRIs Class
39
Table B:
Licenced Indication of SSRIs
41
Table C:
List of Major Antidepressant Drugs Include in SNRIs Class
43
Table D:
List of Major Antidepressant Drugs Include in MAOIs Class
45
Table E:
List of Major Antidepressant Drugs Include in Tricyclic Class
47
Table F:
List of Major Antidepressant Drugs Include in Tetracyclic Class
47
Table G:
List of Major Antidepressant Drugs Include in Benzodiazepines
48
Table H:
List of Major Antidepressant Drugs Include in Antipsychotics
51
Table I:
Antidepressant Drugs Market Analysis, By Drug, Developer, Phase, Indication
61
Table J:
Facts and Figures Driving High Demand of Antidepressants in United States Market
81
17
Research Methodology
Research Definition Global Antidepressant Drugs Market Report comprises of the study of various aspects of antidepressants and forecast until 2023. Global
Antidepressant Drugs Market has been segmented on basis of
Drugs
Class(Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors , Benzodiazepines Antipsychotics Novel Agents); By Sales Channels (Hospital& Clinics, Retail Pharmacies, Others), By Region (North America, Europe, APAC, Middle East and ROW) and By Country (U.S., Canada, Germany, United Kingdom, China, India, Japan, Brazil, Saudi Arabia,).
Data Analysis and Interpretation Our historic market trend has been figured out by various paid databases which was further triangulated with inputs
and
insights
from
industry
experts,
companies
and
stakeholders,
through
primary
research
(manufacturers, marketing managers, others). Back-of-the-Envelope calculation for the market estimation has been made through proper understanding of the market as well as future business strategies of the companies operating in the market.
Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market segmentation, recent trends and developments
and competitive landscape. Our team has conducted extensive primary surveys by
reaching out industry experts across the value chain of the global orthopeadic market.
Companies Contacted: Apollo Pharmacy
18
Global Antidepressant Drugs Market Overview Global Antidepressant Drugs Market has been driven by rising prevalence of depression and anxiety disorders worldwide Figure : Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) CAGR 2013-2017 xxxx%
2013
2014
2015
2016
2017
Source: Azoth Analytics Estimates Xxxx Xxxx Xxxx Xxxx Xxxx Xxxx xxxx
19
Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market
Overview
Figure : Global Monoamine Oxidase Inhibitors Antidepressant
Figure : Global Monoamine Oxidase Inhibitors Antidepressant
Drugs Market, By Value, 2013-2017 (USD Billion)
Drugs Market, By Value, 2018E-2023F (USD Billion)
2013
2014
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates
Xxxxx Xxxxx Xxxxx Xxxxx Xxxxx xxxxx
20
Global Antidepressant Drugs Market - By Sales Channels In the forecast period, Retail Pharmacies are expected to account for the largest share in the market (45.34%) but the Other segment estimated to be the faster growing region.
Figure: Global Antidepressant Drugs Market Size,
Key Drivers
By Sales Channels, 2023 (%)
Xxxxx
Hospitals & Clinics
xxxxx
Retail Pharmacies
Xxxxx Others
xxxxx
Source: Azoth Analytics Estimates
21
Germany Antidepressant Drugs Market, By Drugs Class Figure : Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
2013
CAGR 2013-2017
CAGR 2018-2023
TCAs: xx%; SSRIs: xx%; SNRIs; xx%;
TCAs: xx%; SSRIs: xx%; SNRIs; xx%;
MAOIs: xx%; Benzodiazepines: xx%;
MAOIs: xx%; Benzodiazepines: xx%;
Antipsychotics: xx%; Novel Agents: xx;
Antipsychotics: xx%; Novel Agents: xx;
Others: xx%
Others: xx%
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates 22
United States Antidepressant Drugs Market, By Drugs Class Figure 55: United States Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
CAGR 2018-2023
TCAs: 1.82%; SSRIs: 2.75%; SNRIs;
TCAs: 2.42%; SSRIs: 3.20%; SNRIs;
2.82%; MAOIs: 1.83%; Benzodiazepines:
3.23%; MAOIs: 2.36%; Benzodiazepines:
2.26%; Antipsychotics: 0.73%; Novel
0.23%; Antipsychotics: 0.57%; Novel
Agents: 3.22%; Others:3.30%
Agents: 3.73%; Others:5.78 %
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Tricyclic Antidepressants (TCAs) Selective Serotonin Reuptake (SSRIs) Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Monoamine Oxidase Inhibitors (MAOIs) Benzodiazepines
Antipsychotics Novel Agents Others
Source: Azoth Analytics Estimates 23
About Azoth Analytics Pvt Ltd.
Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).
Related Reports: Global Vitreoretinal Surgery Devices Market (By Product, By End User, By Region, By Country): Opportunities and Forecast (2016-2021) – By Product (Vitrectomy Machines & Packs, Photocoagulation Surgery Devices, Illumination Devices, Others); By End User (Hospitals, Free Standing Ambulatory Surgery Center); By Region (North America, Europe, APAC, ROW); By Country (US, Canada, Mexico, UK, Germany, France, Japan, China, India, Brazil, South Africa) Global Biomaterials Market (By Type, By Applications, By Region): Opportunities and Forecasts (2016-2021) - (By Material Type – Polymer, Ceramic, Metal; By Appliactions - Orthopaedic, Cardiovascular, Plastic Surgery, Wound Care); By Region-North America, Europe, APAC, ROW; By Country – US, UK, Germany, Italy, Japan, China, India; Key Players – Strategy, Financial Performance)
Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for
any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.
24